Medical and Health Science Journal

  Previous Article | Back to Volume | Next Article
  Abstract | References | Citation | Download | Preview | Statistics
Volume 12
Issue 3
Online publication date 2012-07-27
Title Screening for PPAR γ agonist from Myristica fragrans Houtt seeds for the treatment of Type 2 diabetes by in vitro and in vivo
Author Keri Lestari, JK Hwang, Sri Hartini Kariadi, Andi Wijaya, Trihanggono Ahmad, Anas Subarnas, Supriyatna , M. Muchtaridi
Abstract In general, a type two diabetes mellitus (T2DM) patient suffers for hyperglycaemia and insulin resistance. Nowadays, there is an anti diabetes drug working as a PPAR/ agonist and has a significant effect to improve the hyperglycemia and insulin resistance condition. However, this drug gives a negative effect on lipid circulation parameters. In this investigation, nutmeg (Myristica fragrans) extracts (NuSE) was tested against PPARγ using cell-based GAL4/PPAR chimera transactivation and trancient transvection assay with three PPAR response element (PPREs) containing reporters. The results demonstrate that the NuSE has significant PPARγ agonist activity, although their potency was less than the standard PPARγ full agonist. An investigation of antidiabetic activity of the NuSE has been carried out on rats. Rats were treated orally every day for six days with the ethanol of NuSE in several doses. The result of the experiment showed that each dose of NuSE gave hypoglycemic activity (p= 0.01 and p=0.05). The experiment also showed that an increase in dosage caused an increased in the hypoglycemic activity. Therefore, nutmeg (Myristica fragrans) seeds might be potential against antidiabetic agent for the treatment of type two diabetes with a PPAR  /. agonistic mechanism.  
Abate, N. and Chandalia, M., 2003. “The impact of ethnicity on type 2 diabetes,” J Diabetes Complications, Vol.17(1), pp.39-58

Bailey, C. and Day, C., 2001. “Review: Thiazolidinediones today,” The British Journal of Diabetes & Vascular Disease, Vol.1(1), pp.7-13

Belfort, R., Harrison, S., Brown, K., Darland, C., Finch, J., Hardies, J., Balas, B., Gastaldelli, A., Tio, F., Pulcini, J., Berria, R., Ma, J., Dwivedi, S., Havranek, R., Fincke, C., DeFronzo, R., Bannayan, G., Schenker, S., and Cusi, K., 2006. “A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis,” N Engl J Med, Vol.355(22), pp.2297-307

Fracchiolla, G., Laghezza, A., Piemontese, L., Tortorella, P., Mazza, F., Montanari, R., Pochetti, G., Lavecchia, A., Novellino, E., Pierno, S., Conte Camerino, D., and Loiodice, F., 2009. “New 2-aryloxy-3-phenyl-propanoic acids as peroxisome proliferator-activated receptors alpha/gamma dual agonists with improved potency and reduced adverse effects on skeletal muscle function,” J Med Chem, Vol.52(20), pp.6382-393

Gloyn, A., 2003. “The search for type 2 diabetes genes,” Ageing Res Rev, Vol.2(2), pp.111-27

Han, K., Choi, J., Lee, J., Song, J., Joe, M., Jung, M., and Hwang, J., 2008. “Therapeutic potential of peroxisome proliferators--activated receptor-alpha/gamma dual agonist with alleviation of endoplasmic reticulum stress for the treatment of diabetes,” Diabetes, Vol.57(3), pp.737-45

Hauner, H., 2002. “The mode of action of thiazolidinediones,” Diabetes Metab Res Rev, Vol.18(2), pp.10-15

Hwang, J-K., Han, K-L., Sohn, J-H., Kim, A-J., Choo, J-H., Lee, J-Y., and Kim, J-H., 2007. “Method for preventing and treating conditions mediated by PPAR using macelignan,” Patent Application Publication, US 2011/0071221 A1 (patent application), US.

Krentz, A. & Friedmann, P., 2006. “Type 2 diabetes, psoriasis and thiazolidinediones,” Int J Clin Pract, Vol.60(3), pp.362-63

Lehmann, J., Moore, L., Smith-Oliver, T., Wilkison, W., Willson, T. & Kliewer, S., 1995. “An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma),” J Biol Chem, Vol.270(22), pp.12953-956

Montanari, R., Saccoccia, F., Scotti, E., Crestani, M., Godio, C., Gilardi, F., Loiodice, F., Fracchiolla, G., Laghezza, A., Tortorella, P., Lavecchia, A., Novellino, E., Mazza, F., Aschi, M., and Pochetti, G., 2008. “Crystal structure of the peroxisome proliferator-activated receptor gamma (PPARγ) ligand binding domain complexed with a novel partial agonist: a new region of the hydrophobic pocket could be exploited for drug design,” J Med Chem, Vol.51(24), pp.7768-776

Muchtaridi, Subarnas, A., Apriyantono, A., and Mustarichie, R., 2010. “Identification of compounds in the essential oil of nutmeg seeds (Myristica fragrans Houtt.). That inhibit locomotor activity in mice,” International Journal of Molecular Sciences, Vol.11(11), pp.4771-781

Mursiti, S., 2009. Isolasi, karakterisasi, dan uji aktivitas hipoglikemik senyawa dalam biji mahoni bebas minyak dan minyak biji mahoni (Swietenia Macrophylla King)

Olajide, O., Ajayi, F., Ekhelar, A., Awe, S., Makinde, J., and Alada, A., 1999. “Biological effects of Myristica fragrans (nutmeg) extract,” Phytother Res, Vol.13(4), pp.344-45

Ooi, C., Yassin, Z., and Hamid, T., 2010. “Momordica charantia for type 2 diabetes mellitus,” Cochrane Database Syst Rev, Vol.17(2), CD007845

Ram, A., Lauria, P., Gupta, R., and Sharma, V.,  1996. “Hypolipidaemic effect of Myristica fragrans fruit extract in rabbits,” J Ethnopharmacol, Vol.55(1), pp.49-53

Rangwala, S. & Lazar, M., 2004. “Peroxisome proliferator-activated receptor gamma in diabetes and metabolism,” Trends Pharmacol Sci, Vol.25(6), pp.331-36

Riddle, M., 2005. “Glycemic management of type 2 diabetes: An emerging strategy with oral agents, insulins, and combinations,” Endocrinol Metab Clin North Am, Vol.34(1), pp.77-98

Sicree, R., Shaw, J., and Zimmet, P., 2010. Diabetes and impaired glucose tolerance: Prevalence and projections, In  Diabetes Atlas, Vol.4 (pp. 17-71), International Diabetes Federation

Smith, U., 2001. “Pioglitazone: Mechanism of action,” Int J Clin Pract, Suppl(121), pp.13-18

Keywords Nutmeg (Myristica fragrans Houtt.) seeds, antidiabetes, agonist, PPAR /
Pages 7-15
Download Full PDF Download
  Previous Article | Back to Volume | Next Article
Search in articles
Journal Published articles
MHSJ 940
Journal Hits
MHSJ 2306047
Journal Downloads
MHSJ 17101
Total users online -